Pub Date : 2024-11-26DOI: 10.1186/s12880-024-01506-y
Ceren Özeren Keşkek, Emre Aytuğar
Background: This study aimed to perform a comprehensive morphometric analysis of the epiglottis using cone-beam computed tomography (CBCT) images, including the determination of epiglottis dimensions, the investigation of shape variations, and the assessment of their relationship with gender and age.
Methods: A retrospective analysis was conducted on high-quality CBCT images from 100 patients, obtained using the NewTom 5G system. In CBCT images, epiglottis thicknesses (right, midline, left) and horizontal angle at three levels (suprahyoid, hyoid, infrahyoid) were measured in axial sections, while the length and vertical angle of epiglottis were measured in midsagittal view. Epiglottis shapes were identified through 3D visualization.
Results: The midline epiglottis thicknesses were 4.68 mm at the suprahyoid level, 5.51 mm at the hyoid level, and 6.80 mm at the infrahyoid levels. Epiglottis thicknesses and length were statistically significantly greater in males. Of the 100 patients, 51 had a normal curvature, 41 had a flat epiglottis, and 8 had an omega epiglottis. The omega-shaped epiglottis was significantly longer compared to both the flat and normal curvature types (p = 0.011). There was a positive correlation between age and epiglottis thicknesses at the suprahyoid level and horizontal angles at three levels.
Conclusions: This study visualizes epiglottis morphology and uncovers significant morphometric differences. Males exhibit greater epiglottis thickness and length compared to females, while the omega-shaped epiglottis is notably longer than other types. These findings underscore the need for further investigation into the clinical relevance of these morphometric differences, particularly in improving airway management and refining approaches to swallowing function.
{"title":"3D morphometric analysis of the epiglottis using CBCT: age and gender differences.","authors":"Ceren Özeren Keşkek, Emre Aytuğar","doi":"10.1186/s12880-024-01506-y","DOIUrl":"10.1186/s12880-024-01506-y","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to perform a comprehensive morphometric analysis of the epiglottis using cone-beam computed tomography (CBCT) images, including the determination of epiglottis dimensions, the investigation of shape variations, and the assessment of their relationship with gender and age.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on high-quality CBCT images from 100 patients, obtained using the NewTom 5G system. In CBCT images, epiglottis thicknesses (right, midline, left) and horizontal angle at three levels (suprahyoid, hyoid, infrahyoid) were measured in axial sections, while the length and vertical angle of epiglottis were measured in midsagittal view. Epiglottis shapes were identified through 3D visualization.</p><p><strong>Results: </strong>The midline epiglottis thicknesses were 4.68 mm at the suprahyoid level, 5.51 mm at the hyoid level, and 6.80 mm at the infrahyoid levels. Epiglottis thicknesses and length were statistically significantly greater in males. Of the 100 patients, 51 had a normal curvature, 41 had a flat epiglottis, and 8 had an omega epiglottis. The omega-shaped epiglottis was significantly longer compared to both the flat and normal curvature types (p = 0.011). There was a positive correlation between age and epiglottis thicknesses at the suprahyoid level and horizontal angles at three levels.</p><p><strong>Conclusions: </strong>This study visualizes epiglottis morphology and uncovers significant morphometric differences. Males exhibit greater epiglottis thickness and length compared to females, while the omega-shaped epiglottis is notably longer than other types. These findings underscore the need for further investigation into the clinical relevance of these morphometric differences, particularly in improving airway management and refining approaches to swallowing function.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"319"},"PeriodicalIF":2.9,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11590560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142725911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: A deep learning (DL) model that can automatically detect and classify cervical canal and neural foraminal stenosis using cervical spine magnetic resonance imaging (MRI) can improve diagnostic accuracy and efficiency.
Methods: A method comprising region-of-interest (ROI) detection and cascade prediction was formulated for diagnosing cervical spinal stenosis based on a DL model. First, three part-specific convolutional neural networks were employed to detect the ROIs in different parts of the cervical MR images. Cascade prediction of the stenosis categories was subsequently performed to record the stenosis level and position on each patient slice. Finally, the results were combined to obtain a patient-level diagnostic report. Performance was evaluated based on the accuracy (ACC), area under the curve (AUC), sensitivity, specificity, F1 Score, diagnosis time of the DL model, and recall rate for ROI detection localization.
Results: The average recall rate of the ROI localization was 89.3% (neural foramen) and 99.7% (central canal) under the five-fold cross-validation of the DL model. In the dichotomous classification (normal or mild vs. moderate or severe), the ACC and AUC of the DL model were comparable to those of the radiologists, and the F1 score (84.8%) of the DL model was slightly higher than that of the radiologists (83.8%) for the central canal. Diagnosing whether the central canal or neural foramen of a slice is narrowed in the cervical MRI scan required an average of 15 and 0.098 s for the radiologists and DL model, respectively.
Conclusions: The DL model demonstrated comparable performance with subspecialist radiologists for the detection and classification of central canal and neural foraminal stenosis on cervical spine MRI. Moreover, the DL model demonstrated significant timesaving ability.
{"title":"Deep learning model for the automated detection and classification of central canal and neural foraminal stenosis upon cervical spine magnetic resonance imaging.","authors":"Enlong Zhang, Meiyi Yao, Yuan Li, Qizheng Wang, Xinhang Song, Yongye Chen, Ke Liu, Weili Zhao, Xiaoying Xing, Yan Zhou, Fanyu Meng, Hanqiang Ouyang, Gongwei Chen, Liang Jiang, Ning Lang, Shuqiang Jiang, Huishu Yuan","doi":"10.1186/s12880-024-01489-w","DOIUrl":"10.1186/s12880-024-01489-w","url":null,"abstract":"<p><strong>Background: </strong>A deep learning (DL) model that can automatically detect and classify cervical canal and neural foraminal stenosis using cervical spine magnetic resonance imaging (MRI) can improve diagnostic accuracy and efficiency.</p><p><strong>Methods: </strong>A method comprising region-of-interest (ROI) detection and cascade prediction was formulated for diagnosing cervical spinal stenosis based on a DL model. First, three part-specific convolutional neural networks were employed to detect the ROIs in different parts of the cervical MR images. Cascade prediction of the stenosis categories was subsequently performed to record the stenosis level and position on each patient slice. Finally, the results were combined to obtain a patient-level diagnostic report. Performance was evaluated based on the accuracy (ACC), area under the curve (AUC), sensitivity, specificity, F1 Score, diagnosis time of the DL model, and recall rate for ROI detection localization.</p><p><strong>Results: </strong>The average recall rate of the ROI localization was 89.3% (neural foramen) and 99.7% (central canal) under the five-fold cross-validation of the DL model. In the dichotomous classification (normal or mild vs. moderate or severe), the ACC and AUC of the DL model were comparable to those of the radiologists, and the F1 score (84.8%) of the DL model was slightly higher than that of the radiologists (83.8%) for the central canal. Diagnosing whether the central canal or neural foramen of a slice is narrowed in the cervical MRI scan required an average of 15 and 0.098 s for the radiologists and DL model, respectively.</p><p><strong>Conclusions: </strong>The DL model demonstrated comparable performance with subspecialist radiologists for the detection and classification of central canal and neural foraminal stenosis on cervical spine MRI. Moreover, the DL model demonstrated significant timesaving ability.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"320"},"PeriodicalIF":2.9,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11590449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142725914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Virtual histopathology is an emerging technology in medical imaging that utilizes advanced computational methods to analyze tissue images for more precise disease diagnosis. Traditionally, histopathology relies on manual techniques and expertise, often resulting in time-consuming processes and variability in diagnoses. Virtual histopathology offers a more consistent, and automated approach, employing techniques like machine learning, deep learning, and image processing to simulate staining and enhance tissue analysis. This review explores the strengths, limitations, and clinical applications of these methods, highlighting recent advancements in virtual histopathological approaches. In addition, important areas are identified for future research to improve diagnostic accuracy and efficiency in clinical settings.
{"title":"Virtual histopathology methods in medical imaging - a systematic review.","authors":"Muhammad Talha Imran, Imran Shafi, Jamil Ahmad, Muhammad Fasih Uddin Butt, Santos Gracia Villar, Eduardo Garcia Villena, Tahir Khurshaid, Imran Ashraf","doi":"10.1186/s12880-024-01498-9","DOIUrl":"10.1186/s12880-024-01498-9","url":null,"abstract":"<p><p>Virtual histopathology is an emerging technology in medical imaging that utilizes advanced computational methods to analyze tissue images for more precise disease diagnosis. Traditionally, histopathology relies on manual techniques and expertise, often resulting in time-consuming processes and variability in diagnoses. Virtual histopathology offers a more consistent, and automated approach, employing techniques like machine learning, deep learning, and image processing to simulate staining and enhance tissue analysis. This review explores the strengths, limitations, and clinical applications of these methods, highlighting recent advancements in virtual histopathological approaches. In addition, important areas are identified for future research to improve diagnostic accuracy and efficiency in clinical settings.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"318"},"PeriodicalIF":2.9,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11590286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142725917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-21DOI: 10.1186/s12880-024-01499-8
Zifeng Zhang, Ning Li, Yuhang Qian, Huilin Cheng
Objective: Differentiating intramedullary spinal cord tumor (IMSCT) from spinal cord tumefactive demyelinating lesion (scTDL) remains challenging with standard diagnostic approaches. This study aims to develop and evaluate the effectiveness of a magnetic resonance imaging (MRI)-based radiomics model for distinguishing scTDL from IMSCT before treatment initiation.
Methods: A total of 75 patients were analyzed in this retrospective study, comprising 55 with IMSCT and 20 with scTDL. Radiomics features were extracted from T1- and T2-weighted imaging (T1&T2WI) scans upon admission. Ten classification algorithms were employed: logistic regression (LR); naive bayes (NaiveBayes); support vector machine (SVM); k nearest neighbors (KNN); random forest (RF); extra trees (ExtraTrees); eXtreme gradient boosting (XGBoost); light gradient boosting machine (LightGBM); gradient boosting (GradientBoosting); and multi-Layer perceptron (MLP). The performance of the optimal model was then compared to radiologists' assessments.
Results: This study developed 30 predictive models using ten classifiers across two imaging sequences. The MLP model with two sequences (T1&T2WI) emerged as the most effective one, showing superior accuracy in MRI analysis with an area under the curve (AUC) of 0.991 in training and 0.962 in testing. Moreover, statistical analyses highlighted the radiomics model significantly outperformed radiologists' assessments (p < 0.05) in distinguishing between IMSCT and scTDL.
Conclusion: We present an MRI-based radiomics model with high diagnostic accuracy in differentiating IMSCT from scTDL. The model's performance was comparable to junior radiologists, highlighting its potential as an effective diagnostic aid in clinical practice.
{"title":"Establishment of an MRI-based radiomics model for distinguishing between intramedullary spinal cord tumor and tumefactive demyelinating lesion.","authors":"Zifeng Zhang, Ning Li, Yuhang Qian, Huilin Cheng","doi":"10.1186/s12880-024-01499-8","DOIUrl":"10.1186/s12880-024-01499-8","url":null,"abstract":"<p><strong>Objective: </strong>Differentiating intramedullary spinal cord tumor (IMSCT) from spinal cord tumefactive demyelinating lesion (scTDL) remains challenging with standard diagnostic approaches. This study aims to develop and evaluate the effectiveness of a magnetic resonance imaging (MRI)-based radiomics model for distinguishing scTDL from IMSCT before treatment initiation.</p><p><strong>Methods: </strong>A total of 75 patients were analyzed in this retrospective study, comprising 55 with IMSCT and 20 with scTDL. Radiomics features were extracted from T1- and T2-weighted imaging (T1&T2WI) scans upon admission. Ten classification algorithms were employed: logistic regression (LR); naive bayes (NaiveBayes); support vector machine (SVM); k nearest neighbors (KNN); random forest (RF); extra trees (ExtraTrees); eXtreme gradient boosting (XGBoost); light gradient boosting machine (LightGBM); gradient boosting (GradientBoosting); and multi-Layer perceptron (MLP). The performance of the optimal model was then compared to radiologists' assessments.</p><p><strong>Results: </strong>This study developed 30 predictive models using ten classifiers across two imaging sequences. The MLP model with two sequences (T1&T2WI) emerged as the most effective one, showing superior accuracy in MRI analysis with an area under the curve (AUC) of 0.991 in training and 0.962 in testing. Moreover, statistical analyses highlighted the radiomics model significantly outperformed radiologists' assessments (p < 0.05) in distinguishing between IMSCT and scTDL.</p><p><strong>Conclusion: </strong>We present an MRI-based radiomics model with high diagnostic accuracy in differentiating IMSCT from scTDL. The model's performance was comparable to junior radiologists, highlighting its potential as an effective diagnostic aid in clinical practice.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"317"},"PeriodicalIF":2.9,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11583559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142685945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-20DOI: 10.1186/s12880-024-01488-x
Anna E Caprifico, Luca Vaghi, Peter Spearman, Gianpiero Calabrese, Antonio Papagni
Introduction: The treatment of preinvasive lesions is more effective than treating invasive disease, hence detecting cancer at its early stages is crucial. However, currently, available screening methods show various limitations in terms of sensitivity, specificity, and practicality, thus novel markers complementing traditional cyto/histopathological assessments are needed. Alteration in choline metabolism is a hallmark of many malignancies, including cervical and breast cancers. Choline radiotracers are widely used for imaging purposes, even though many risks are associated with their radioactivity. Therefore, this work aimed to synthesise and characterise a non-radioactive choline tracer based on a fluorinated acridine scaffold (CFA) for the in vitro detection of cervical and breast cancer cells by fluorescence imaging.
Methods: CFA was fully characterised and tested for its cytotoxicity on breast (MCF-7), cervical (HeLa), glioblastoma (U-87 MG) and hepatoblastoma (HepG2) cancer cell lines and in normal cell lines (epithelial, HEK-293 and human dermal fibroblasts, HDFs). The cellular uptake of CFA was investigated by a confocal microscope and its accumulation was quantified over time. The specificity of CFA over mesenchymal origin cells (HDFs), as a model of cancer-associated fibroblasts was investigated by fluorescence microscopy.
Results: CFA was toxic at much higher concentrations (HeLa IC50 = 200 ± 18 µM and MCF-7 IC50 = 105 ± 3 µM) than needed for its detection in cancer cells (5 µM). CFA was not toxic in the other cell lines tested. The intensity of CFA in breast and cervical cancer cells was not significantly different at any time point, yet it was greater than HepG2 and U-87 MG (p ≤ 0.01 and p ≤ 0.0001, respectively) after 24 h incubation. A very weak signal intensity was recorded in HEK-293 and HDFs (p ≤ 0.001 and p ≤ 0.0001, respectively). A selective ability of CFA to accumulate in HeLa and MCF-7 was recorded upon co-culture with fibroblasts.
Conclusions: The results showed that CFA preferentially accumulated in cancer cells rather than in normal cells. These findings suggest that CFA may be a potential diagnostic probe for discriminating healthy tissues from malignant tissues due to its specific and highly sensitive features; CFA may also represent a useful tool for in vitro/ex vivo investigations of choline metabolism in patients with cervical and breast cancers.
导读治疗浸润前病变比治疗浸润性疾病更有效,因此在早期阶段检测癌症至关重要。然而,目前可用的筛查方法在灵敏度、特异性和实用性方面存在各种局限性,因此需要新的标记物来补充传统的细胞学/组织病理学评估。胆碱代谢的改变是包括宫颈癌和乳腺癌在内的许多恶性肿瘤的标志。胆碱放射性racers 被广泛用于成像目的,尽管其放射性存在许多风险。因此,这项研究旨在合成一种基于含氟吖啶支架(CFA)的非放射性胆碱示踪剂,并对其进行表征,以便通过荧光成像对宫颈癌和乳腺癌细胞进行体外检测:对 CFA 进行了全面鉴定,并测试了它对乳腺癌(MCF-7)、宫颈癌(HeLa)、胶质母细胞瘤(U-87 MG)和肝母细胞瘤(HepG2)细胞系以及正常细胞系(上皮细胞、HEK-293 和人真皮成纤维细胞,HDFs)的细胞毒性。共聚焦显微镜研究了细胞对 CFA 的摄取情况,并对其随时间的积累进行了量化。通过荧光显微镜研究了作为癌症相关成纤维细胞模型的间充质细胞(HDFs)对 CFA 的特异性:CFA的毒性浓度(HeLa IC50 = 200 ± 18 µM,MCF-7 IC50 = 105 ± 3 µM)远高于其在癌细胞中的检测浓度(5 µM)。在测试的其他细胞系中,CFA 没有毒性。乳腺癌和宫颈癌细胞中 CFA 的强度在任何时间点都没有显著差异,但在孵育 24 小时后,其强度高于 HepG2 和 U-87 MG(分别为 p ≤ 0.01 和 p ≤ 0.0001)。在 HEK-293 和 HDFs 中记录到的信号强度很弱(分别为 p≤0.001 和 p≤0.0001)。在与成纤维细胞共培养时,CFA在HeLa和MCF-7中具有选择性蓄积能力:结论:研究结果表明,CFA 优先在癌细胞而非正常细胞中积累。这些研究结果表明,由于 CFA 具有特异性和高灵敏度的特点,它可能是鉴别健康组织和恶性组织的潜在诊断探针;CFA 也可能是宫颈癌和乳腺癌患者体内/体外胆碱代谢研究的有用工具。
{"title":"In vitro detection of cancer cells using a novel fluorescent choline derivative.","authors":"Anna E Caprifico, Luca Vaghi, Peter Spearman, Gianpiero Calabrese, Antonio Papagni","doi":"10.1186/s12880-024-01488-x","DOIUrl":"10.1186/s12880-024-01488-x","url":null,"abstract":"<p><strong>Introduction: </strong>The treatment of preinvasive lesions is more effective than treating invasive disease, hence detecting cancer at its early stages is crucial. However, currently, available screening methods show various limitations in terms of sensitivity, specificity, and practicality, thus novel markers complementing traditional cyto/histopathological assessments are needed. Alteration in choline metabolism is a hallmark of many malignancies, including cervical and breast cancers. Choline radiotracers are widely used for imaging purposes, even though many risks are associated with their radioactivity. Therefore, this work aimed to synthesise and characterise a non-radioactive choline tracer based on a fluorinated acridine scaffold (CFA) for the in vitro detection of cervical and breast cancer cells by fluorescence imaging.</p><p><strong>Methods: </strong>CFA was fully characterised and tested for its cytotoxicity on breast (MCF-7), cervical (HeLa), glioblastoma (U-87 MG) and hepatoblastoma (HepG2) cancer cell lines and in normal cell lines (epithelial, HEK-293 and human dermal fibroblasts, HDFs). The cellular uptake of CFA was investigated by a confocal microscope and its accumulation was quantified over time. The specificity of CFA over mesenchymal origin cells (HDFs), as a model of cancer-associated fibroblasts was investigated by fluorescence microscopy.</p><p><strong>Results: </strong>CFA was toxic at much higher concentrations (HeLa IC<sub>50</sub> = 200 ± 18 µM and MCF-7 IC<sub>50</sub> = 105 ± 3 µM) than needed for its detection in cancer cells (5 µM). CFA was not toxic in the other cell lines tested. The intensity of CFA in breast and cervical cancer cells was not significantly different at any time point, yet it was greater than HepG2 and U-87 MG (p ≤ 0.01 and p ≤ 0.0001, respectively) after 24 h incubation. A very weak signal intensity was recorded in HEK-293 and HDFs (p ≤ 0.001 and p ≤ 0.0001, respectively). A selective ability of CFA to accumulate in HeLa and MCF-7 was recorded upon co-culture with fibroblasts.</p><p><strong>Conclusions: </strong>The results showed that CFA preferentially accumulated in cancer cells rather than in normal cells. These findings suggest that CFA may be a potential diagnostic probe for discriminating healthy tissues from malignant tissues due to its specific and highly sensitive features; CFA may also represent a useful tool for in vitro/ex vivo investigations of choline metabolism in patients with cervical and breast cancers.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"316"},"PeriodicalIF":2.9,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11580358/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142680562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-18DOI: 10.1186/s12880-024-01469-0
Peng Huang, Hui Yan, Jiawen Shang, Xin Xie
Background and purpose: Tumor bed (TB) is the residual cavity of resected tumor after surgery. Delineating TB from CT is crucial in generating clinical target volume for radiotherapy. Due to multiple surgical effects and low image contrast, segmenting TB from soft tissue is challenging. In clinical practice, titanium clips were used as marks to guide the searching of TB. However, this information is limited and may cause large error. To provide more prior location information, the tumor regions on both pre-operative and post-operative CTs are both used by the deep learning model in segmenting TB from surrounding tissues.
Materials and methods: For breast cancer patient after surgery and going to be treated by radiotherapy, it is important to delineate the target volume for treatment planning. In clinical practice, the target volume is usually generated from TB by adding a certain margin. Therefore, it is crucial to identify TB from soft tissue. To facilitate this process, a deep learning model is developed to segment TB from CT with the guidance of prior tumor location. Initially, the tumor contour on the pre-operative CT is delineated by physician for surgical planning purpose. Then this contour is transformed to the post-operative CT via the deformable image registration between paired pre-operative and post-operative CTs. The original and transformed tumor regions are both used as inputs for predicting the possible region of TB by the deep-learning model.
Results: Compared to the one without prior tumor contour information, the dice similarity coefficient of the deep-learning model with the prior tumor contour information is improved significantly (0.812 vs. 0.520, P = 0.001). Compared to the traditional gray-level thresholding method, the dice similarity coefficient of the deep-learning model with the prior tumor contour information is improved significantly (0.812 vs.0.633, P = 0.0005).
Conclusions: The prior tumor contours on both pre-operative and post-operative CTs provide valuable information in searching for the precise location of TB on post-operative CT. The proposed method provided a feasible way to assist auto-segmentation of TB in treatment planning of radiotherapy after breast-conserving surgery.
{"title":"Prior information guided deep-learning model for tumor bed segmentation in breast cancer radiotherapy.","authors":"Peng Huang, Hui Yan, Jiawen Shang, Xin Xie","doi":"10.1186/s12880-024-01469-0","DOIUrl":"10.1186/s12880-024-01469-0","url":null,"abstract":"<p><strong>Background and purpose: </strong>Tumor bed (TB) is the residual cavity of resected tumor after surgery. Delineating TB from CT is crucial in generating clinical target volume for radiotherapy. Due to multiple surgical effects and low image contrast, segmenting TB from soft tissue is challenging. In clinical practice, titanium clips were used as marks to guide the searching of TB. However, this information is limited and may cause large error. To provide more prior location information, the tumor regions on both pre-operative and post-operative CTs are both used by the deep learning model in segmenting TB from surrounding tissues.</p><p><strong>Materials and methods: </strong>For breast cancer patient after surgery and going to be treated by radiotherapy, it is important to delineate the target volume for treatment planning. In clinical practice, the target volume is usually generated from TB by adding a certain margin. Therefore, it is crucial to identify TB from soft tissue. To facilitate this process, a deep learning model is developed to segment TB from CT with the guidance of prior tumor location. Initially, the tumor contour on the pre-operative CT is delineated by physician for surgical planning purpose. Then this contour is transformed to the post-operative CT via the deformable image registration between paired pre-operative and post-operative CTs. The original and transformed tumor regions are both used as inputs for predicting the possible region of TB by the deep-learning model.</p><p><strong>Results: </strong>Compared to the one without prior tumor contour information, the dice similarity coefficient of the deep-learning model with the prior tumor contour information is improved significantly (0.812 vs. 0.520, P = 0.001). Compared to the traditional gray-level thresholding method, the dice similarity coefficient of the deep-learning model with the prior tumor contour information is improved significantly (0.812 vs.0.633, P = 0.0005).</p><p><strong>Conclusions: </strong>The prior tumor contours on both pre-operative and post-operative CTs provide valuable information in searching for the precise location of TB on post-operative CT. The proposed method provided a feasible way to assist auto-segmentation of TB in treatment planning of radiotherapy after breast-conserving surgery.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"312"},"PeriodicalIF":2.9,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571877/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-18DOI: 10.1186/s12880-024-01473-4
Yuxin Zhang, Xu Cheng, Xianli Luo, Ruixia Sun, Xiang Huang, Lingling Liu, Min Zhu, Xueling Li
Background: Esophageal fistula (EF), a rare and potentially fatal complication, can be better managed with predictive models for personalized treatment plans in esophageal cancers. We aim to develop a clinical-deep learning radiomics model for effectively predicting the occurrence of EF.
Methods: The study involved esophageal cancer patients undergoing radiotherapy or chemoradiotherapy. Arterial phase enhanced CT images were used to extract handcrafted and deep learning radiomic features. Along with clinical information, a 3-step feature selection method (statistical tests, Least Absolute Shrinkage and Selection Operator, and Recursive Feature Elimination) was used to identify five feature sets in training cohort for constructing random forest EF prediction models. Model performance was compared and validated in both retrospective and prospective test cohorts.
Results: One hundred seventy five patients (122 in training and 53 in test cohort)were retrospectively collected from April 2018 to June 2022. An additional 27 patients were enrolled as a prospective test cohort from June 2022 to December 2023. Post-selection in the training cohort, five feature sets were used for model construction: clinical, handcrafted radiomic, deep learning radiomic, clinical-handcrafted radiomic, and clinical-deep learning radiomic. The clinical-deep learning radiomic model excelled with AUC of 0.89 (95% Confidence Interval: 0.83-0.95) in the training cohort, 0.81 (0.65-0.94) in the test cohort, and 0.85 (0.71-0.97) in the prospective test cohort. Brier-score and calibration curve analyses validated its predictive ability.
Conclusions: The clinical-deep learning radiomic model can effectively predict EF in patients with advanced esophageal cancer undergoing radiotherapy or chemoradiotherapy.
{"title":"Prediction of esophageal fistula in radiotherapy/chemoradiotherapy for patients with advanced esophageal cancer by a clinical-deep learning radiomics model : Prediction of esophageal fistula in radiotherapy/chemoradiotherapy patients.","authors":"Yuxin Zhang, Xu Cheng, Xianli Luo, Ruixia Sun, Xiang Huang, Lingling Liu, Min Zhu, Xueling Li","doi":"10.1186/s12880-024-01473-4","DOIUrl":"10.1186/s12880-024-01473-4","url":null,"abstract":"<p><strong>Background: </strong>Esophageal fistula (EF), a rare and potentially fatal complication, can be better managed with predictive models for personalized treatment plans in esophageal cancers. We aim to develop a clinical-deep learning radiomics model for effectively predicting the occurrence of EF.</p><p><strong>Methods: </strong>The study involved esophageal cancer patients undergoing radiotherapy or chemoradiotherapy. Arterial phase enhanced CT images were used to extract handcrafted and deep learning radiomic features. Along with clinical information, a 3-step feature selection method (statistical tests, Least Absolute Shrinkage and Selection Operator, and Recursive Feature Elimination) was used to identify five feature sets in training cohort for constructing random forest EF prediction models. Model performance was compared and validated in both retrospective and prospective test cohorts.</p><p><strong>Results: </strong>One hundred seventy five patients (122 in training and 53 in test cohort)were retrospectively collected from April 2018 to June 2022. An additional 27 patients were enrolled as a prospective test cohort from June 2022 to December 2023. Post-selection in the training cohort, five feature sets were used for model construction: clinical, handcrafted radiomic, deep learning radiomic, clinical-handcrafted radiomic, and clinical-deep learning radiomic. The clinical-deep learning radiomic model excelled with AUC of 0.89 (95% Confidence Interval: 0.83-0.95) in the training cohort, 0.81 (0.65-0.94) in the test cohort, and 0.85 (0.71-0.97) in the prospective test cohort. Brier-score and calibration curve analyses validated its predictive ability.</p><p><strong>Conclusions: </strong>The clinical-deep learning radiomic model can effectively predict EF in patients with advanced esophageal cancer undergoing radiotherapy or chemoradiotherapy.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"313"},"PeriodicalIF":2.9,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11571992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Ovarian cancer remains a leading cause of death among women, largely due to its asymptomatic early stages and high mortality when diagnosed late. Early detection significantly improves survival rates, and the Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US) is currently the most commonly used method, but has limitations in specificity and accuracy. While O-RADS US has standardized reporting, its sensitivity can lead to the misdiagnosis of benign masses as malignant, resulting in overtreatment. This study aimed to construct a nomogram model based on the O-RADS US and clinical and laboratory indicators to predict the malignancy risk of adnexal cystic-solid masses.
Methods: This retrospective study collected data from patients with adnexal cystic-solid masses who underwent ultrasonography and were pathologically confirmed between January 2021 and December 2023 at the First Affiliated Hospital of Shenzhen University. They were categorized into benign and malignant groups according to pathological findings. Least absolute shrinkage and selection operator (LASSO) regression analysis was used to select the most relevant predictors of ovarian cancer. A nomogram model was constructed, and its diagnostic performance was calculated. We bootstrapped the data 500 times to perform internal verification, drew a calibration curve to verify the prediction ability, and performed a decision curve analysis to assess clinical usefulness.
Results: A total of 399 patients with adnexal cystic-solid masses were included in this study: 327 in the benign group and 72 in the malignant group. Five predictors associated with the risk of malignancy of adnexal cystic-solid masses were selected using LASSO regression: O-RADS, acoustic shadowing, postmenopausal status, CA125, and HE4. The area under the curve, sensitivity, specificity, accuracy, positive and negative predictive values of the nomogram were 0.909, 83.3%, 82.9%, 83.0%, 51.7%, and 95.8%, respectively. The calibration curve of the nomogram showed good consistency between the predicted and actual probabilities, and the decision curve showed good clinical usefulness.
Conclusion: The nomogram model based on O-RADS US and clinical and laboratory indicators can be used to predict the risk of malignancy in adnexal cystic-solid masses, with high predictive performance, good calibration, and clinical usefulness.
背景:卵巢癌仍然是导致妇女死亡的主要原因之一,这主要是由于卵巢癌早期无症状,晚期诊断时死亡率很高。早期发现可大大提高生存率,而卵巢-附件报告和数据系统超声检查(O-RADS US)是目前最常用的方法,但在特异性和准确性方面存在局限性。虽然 O-RADS US 具有标准化报告的特点,但其敏感性可能导致良性肿块被误诊为恶性肿块,从而造成过度治疗。本研究旨在构建一个基于 O-RADS US 和临床及实验室指标的提名图模型,以预测附件囊实性肿块的恶性风险:这项回顾性研究收集了2021年1月至2023年12月期间在深圳大学附属第一医院接受超声检查并经病理证实的附件囊实性肿块患者的数据。根据病理结果分为良性和恶性两组。采用最小绝对收缩和选择算子(LASSO)回归分析来选择与卵巢癌最相关的预测因子。我们构建了一个提名图模型,并计算了其诊断性能。我们对数据进行了500次引导以进行内部验证,绘制了校准曲线以验证预测能力,并进行了决策曲线分析以评估临床实用性:结果:本研究共纳入了 399 例附件囊实性肿块患者:良性组 327 例,恶性组 72 例。采用 LASSO 回归法选出了与附件囊实性肿块恶性风险相关的五个预测因子:O-RADS、声影、绝经后状态、CA125 和 HE4。提名图的曲线下面积、灵敏度、特异性、准确性、阳性预测值和阴性预测值分别为 0.909、83.3%、82.9%、83.0%、51.7% 和 95.8%。提名图的校准曲线显示预测概率与实际概率之间具有良好的一致性,决策曲线显示了良好的临床实用性:基于 O-RADS US 和临床及实验室指标的提名图模型可用于预测附件囊实性肿块的恶性肿瘤风险,具有较高的预测性能、良好的校准性和临床实用性。
{"title":"The predictive value of nomogram for adnexal cystic-solid masses based on O-RADS US, clinical and laboratory indicators.","authors":"Chunchun Jin, Meifang Deng, Yanling Bei, Chan Zhang, Shiya Wang, Shun Yang, Lvhuan Qiu, Xiuyan Liu, Qiuxiang Chen","doi":"10.1186/s12880-024-01497-w","DOIUrl":"10.1186/s12880-024-01497-w","url":null,"abstract":"<p><strong>Background: </strong>Ovarian cancer remains a leading cause of death among women, largely due to its asymptomatic early stages and high mortality when diagnosed late. Early detection significantly improves survival rates, and the Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US) is currently the most commonly used method, but has limitations in specificity and accuracy. While O-RADS US has standardized reporting, its sensitivity can lead to the misdiagnosis of benign masses as malignant, resulting in overtreatment. This study aimed to construct a nomogram model based on the O-RADS US and clinical and laboratory indicators to predict the malignancy risk of adnexal cystic-solid masses.</p><p><strong>Methods: </strong>This retrospective study collected data from patients with adnexal cystic-solid masses who underwent ultrasonography and were pathologically confirmed between January 2021 and December 2023 at the First Affiliated Hospital of Shenzhen University. They were categorized into benign and malignant groups according to pathological findings. Least absolute shrinkage and selection operator (LASSO) regression analysis was used to select the most relevant predictors of ovarian cancer. A nomogram model was constructed, and its diagnostic performance was calculated. We bootstrapped the data 500 times to perform internal verification, drew a calibration curve to verify the prediction ability, and performed a decision curve analysis to assess clinical usefulness.</p><p><strong>Results: </strong>A total of 399 patients with adnexal cystic-solid masses were included in this study: 327 in the benign group and 72 in the malignant group. Five predictors associated with the risk of malignancy of adnexal cystic-solid masses were selected using LASSO regression: O-RADS, acoustic shadowing, postmenopausal status, CA125, and HE4. The area under the curve, sensitivity, specificity, accuracy, positive and negative predictive values of the nomogram were 0.909, 83.3%, 82.9%, 83.0%, 51.7%, and 95.8%, respectively. The calibration curve of the nomogram showed good consistency between the predicted and actual probabilities, and the decision curve showed good clinical usefulness.</p><p><strong>Conclusion: </strong>The nomogram model based on O-RADS US and clinical and laboratory indicators can be used to predict the risk of malignancy in adnexal cystic-solid masses, with high predictive performance, good calibration, and clinical usefulness.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"315"},"PeriodicalIF":2.9,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In recent years, the incidence of nodular thyroid diseases has been increasing annually. Ultrasonography has become a routine diagnostic tool for thyroid nodules due to its high real-time capabilities and low invasiveness. However, thyroid images obtained from current ultrasound tests often have low resolution and are plagued by significant noise interference. Regional differences in medical conditions and varying levels of physician experience can impact the accuracy and efficiency of diagnostic results. With the advancement of deep learning technology, deep learning models are used to identify whether a nodule in a thyroid ultrasound image is benign or malignant. This helps to close the gap between doctors' experience and equipment differences, improving the accuracy of the initial diagnosis of thyroid nodules. To cope with the problem that thyroid ultrasound images contain complex background and noise as well as poorly defined local features. in this paper, we first construct an improved ResNet50 classification model that uses a two-branch input and incorporates a global attention lightening module. This model is used to improve the accuracy of benign and malignant nodule classification in thyroid ultrasound images and to reduce the computational effort due to the two-branch structure.We constructed a U-net segmentation model incorporating our proposed ACR module, which uses hollow convolution with different dilation rates to capture multi-scale contextual information for feature extraction of nodules in thyroid ultrasound images and uses the results of the segmentation task as an auxiliary branch for the classification task to guide the classification model to focus on the lesion region more efficiently in the case of weak local features. The classification model is guided to focus on the lesion region more efficiently, and the classification and segmentation sub-networks are respectively improved specifically for this study, which is used to improve the accuracy of classifying the benign and malignant nature of the nodules in thyroid ultrasound images. The experimental results show that the four evaluation metrics of accuracy, precision, recall, and f1 of the improved model are 96.01%, 93.3%, 98.8%, and 96.0%, respectively. The improvements were 5.7%, 1.6%, 13.1%, and 7.4%, respectively, compared with the baseline classification model.
近年来,甲状腺结节性疾病的发病率逐年上升。超声波检查因其实时性高、创伤小而成为甲状腺结节的常规诊断工具。然而,目前的超声检测所获得的甲状腺图像分辨率往往较低,且存在明显的噪声干扰。医疗条件的地区差异和医生经验水平的不同都会影响诊断结果的准确性和效率。随着深度学习技术的发展,深度学习模型可用于识别甲状腺超声图像中的结节是良性还是恶性。这有助于缩小医生经验与设备差异之间的差距,提高甲状腺结节初步诊断的准确性。针对甲状腺超声图像包含复杂背景和噪声以及局部特征不明确的问题,本文首先构建了一个改进的 ResNet50 分类模型,该模型使用双分支输入,并结合了全局注意力减弱模块。该模型用于提高甲状腺超声图像中良性和恶性结节分类的准确性,并减少双分支结构带来的计算量。我们构建了一个 U 网分割模型,其中包含了我们提出的 ACR 模块,该模块使用不同扩张率的空心卷积来捕捉甲状腺超声图像中结节的多尺度上下文信息,用于特征提取,并将分割任务的结果作为分类任务的辅助分支,在局部特征较弱的情况下引导分类模型更有效地聚焦于病变区域。在引导分类模型更有效地关注病变区域的基础上,分别对分类子网络和分割子网络进行了专门改进,用于提高甲状腺超声图像中结节良恶性分类的准确性。实验结果表明,改进模型的准确率、精确度、召回率和 f1 四个评价指标分别为 96.01%、93.3%、98.8% 和 96.0%。与基线分类模型相比,分别提高了 5.7%、1.6%、13.1% 和 7.4%。
{"title":"The study on ultrasound image classification using a dual-branch model based on Resnet50 guided by U-net segmentation results.","authors":"Xu Yang, Shuo'ou Qu, Zhilin Wang, Lingxiao Li, Xiaofeng An, Zhibin Cong","doi":"10.1186/s12880-024-01486-z","DOIUrl":"10.1186/s12880-024-01486-z","url":null,"abstract":"<p><p>In recent years, the incidence of nodular thyroid diseases has been increasing annually. Ultrasonography has become a routine diagnostic tool for thyroid nodules due to its high real-time capabilities and low invasiveness. However, thyroid images obtained from current ultrasound tests often have low resolution and are plagued by significant noise interference. Regional differences in medical conditions and varying levels of physician experience can impact the accuracy and efficiency of diagnostic results. With the advancement of deep learning technology, deep learning models are used to identify whether a nodule in a thyroid ultrasound image is benign or malignant. This helps to close the gap between doctors' experience and equipment differences, improving the accuracy of the initial diagnosis of thyroid nodules. To cope with the problem that thyroid ultrasound images contain complex background and noise as well as poorly defined local features. in this paper, we first construct an improved ResNet50 classification model that uses a two-branch input and incorporates a global attention lightening module. This model is used to improve the accuracy of benign and malignant nodule classification in thyroid ultrasound images and to reduce the computational effort due to the two-branch structure.We constructed a U-net segmentation model incorporating our proposed ACR module, which uses hollow convolution with different dilation rates to capture multi-scale contextual information for feature extraction of nodules in thyroid ultrasound images and uses the results of the segmentation task as an auxiliary branch for the classification task to guide the classification model to focus on the lesion region more efficiently in the case of weak local features. The classification model is guided to focus on the lesion region more efficiently, and the classification and segmentation sub-networks are respectively improved specifically for this study, which is used to improve the accuracy of classifying the benign and malignant nature of the nodules in thyroid ultrasound images. The experimental results show that the four evaluation metrics of accuracy, precision, recall, and f1 of the improved model are 96.01%, 93.3%, 98.8%, and 96.0%, respectively. The improvements were 5.7%, 1.6%, 13.1%, and 7.4%, respectively, compared with the baseline classification model.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"314"},"PeriodicalIF":2.9,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11575176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142666662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-15DOI: 10.1186/s12880-024-01496-x
Wanying Li, Yiyan Du, Yao Wei, Ruie Feng, Ying Wang, Xiao Yang, Hongyan Wang, Jianchu Li
Background: Thyroid nodules diagnosed in children pose a greater risk of malignancy compared to those in adults. However, there is no ultrasound thyroid nodule evaluation system aimed at children. The objective of this research is to assess the diagnostic performance of the adult-based American College of Radiology Thyroid Imaging Reporting and Data System (ACR-TIRADS) and Chinese Thyroid Imaging Reporting and Data System (C-TIRADS) in pediatric thyroid carcinoma.
Methods: The preoperative ultrasound images of 177 thyroid lesions in 136 pediatric patients aged 18 or younger who underwent thyroid surgery or fine needle aspiration (FNA) at our center from July 2017 to July 2022 were reviewed. The sonographic characteristics of pediatric thyroid carcinoma were compared and analyzed in contrast to benign nodules. All the nodules were evaluated by the ACR-TIRADS and the C-TIRADS respectively.
Results: Ultrasound features such as solid composition (94.8%), hypoechogenicity or marked hypoechogenicity (94.8-95.7%) and microcalcification (78.3-84.3%) were more common in pediatric malignant nodules (P-values < 0.05). The areas under receiver operating characteristic curves (AUC) of the ACR-TIRADS and the C-TIRADS in diagnosing pediatric thyroid carcinoma were 0.903-0.906, 0.907-0.909 (P-value > 0.05). The interobserver agreement of both the ACR-TIRADS and the C-TIRADS was strong (weighted Kappa > 0.90).
Conclusions: Both the C-TIRADS and the ACR-TIRADS owned great diagnostic performance and strong interobserver agreement in diagnosing pediatric thyroid carcinoma. However, a more complete and specific ultrasound evaluation system for pediatric thyroid nodules is still needed.
{"title":"Diagnostic performance of adult-based thyroid imaging reporting and data systems in pediatric thyroid carcinoma: a retrospective study.","authors":"Wanying Li, Yiyan Du, Yao Wei, Ruie Feng, Ying Wang, Xiao Yang, Hongyan Wang, Jianchu Li","doi":"10.1186/s12880-024-01496-x","DOIUrl":"10.1186/s12880-024-01496-x","url":null,"abstract":"<p><strong>Background: </strong>Thyroid nodules diagnosed in children pose a greater risk of malignancy compared to those in adults. However, there is no ultrasound thyroid nodule evaluation system aimed at children. The objective of this research is to assess the diagnostic performance of the adult-based American College of Radiology Thyroid Imaging Reporting and Data System (ACR-TIRADS) and Chinese Thyroid Imaging Reporting and Data System (C-TIRADS) in pediatric thyroid carcinoma.</p><p><strong>Methods: </strong>The preoperative ultrasound images of 177 thyroid lesions in 136 pediatric patients aged 18 or younger who underwent thyroid surgery or fine needle aspiration (FNA) at our center from July 2017 to July 2022 were reviewed. The sonographic characteristics of pediatric thyroid carcinoma were compared and analyzed in contrast to benign nodules. All the nodules were evaluated by the ACR-TIRADS and the C-TIRADS respectively.</p><p><strong>Results: </strong>Ultrasound features such as solid composition (94.8%), hypoechogenicity or marked hypoechogenicity (94.8-95.7%) and microcalcification (78.3-84.3%) were more common in pediatric malignant nodules (P-values < 0.05). The areas under receiver operating characteristic curves (AUC) of the ACR-TIRADS and the C-TIRADS in diagnosing pediatric thyroid carcinoma were 0.903-0.906, 0.907-0.909 (P-value > 0.05). The interobserver agreement of both the ACR-TIRADS and the C-TIRADS was strong (weighted Kappa > 0.90).</p><p><strong>Conclusions: </strong>Both the C-TIRADS and the ACR-TIRADS owned great diagnostic performance and strong interobserver agreement in diagnosing pediatric thyroid carcinoma. However, a more complete and specific ultrasound evaluation system for pediatric thyroid nodules is still needed.</p>","PeriodicalId":9020,"journal":{"name":"BMC Medical Imaging","volume":"24 1","pages":"311"},"PeriodicalIF":2.9,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568523/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142643482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}